Trials / Recruiting
RecruitingNCT05331066
Understanding immunE-related toXicities by multifACeT Profiling
EXACT - Understanding immunE-related toXicities by multifACeT Profiling
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective observational cohort study of patients undergoing CPI therapy in which translational research is the fundamental aspect of the study.
Detailed description
The study aims to enroll and obtain samples of investigational interest from 200 patients over a 36-month recruitment period. Blood and/ or stool samples will be taken at baseline, in context of irAE development / during CPI treatment and during follow-up. Skin samples may also be taken upon development of organspeciifc irAEs. Further assessments at baseline or during the course of or following treatment will be conducted in accordance with standard institutional practice and will be clinically driven. Clinical data, samples and results from archival, current or prospective diagnostic or therapeutic procedures will be used for research purposes within EXACT. IrAE clinical monitoring will be conducted in accordance with standard institutional practice and will be clinically driven.
Conditions
Timeline
- Start date
- 2022-04-06
- Primary completion
- 2028-04-06
- Completion
- 2028-04-06
- First posted
- 2022-04-15
- Last updated
- 2025-10-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05331066. Inclusion in this directory is not an endorsement.